152 related articles for article (PubMed ID: 16826054)
1. Botulinum toxin A for neuropathic pain after neck dissection: a dose-finding study.
Wittekindt C; Liu WC; Preuss SF; Guntinas-Lichius O
Laryngoscope; 2006 Jul; 116(7):1168-71. PubMed ID: 16826054
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin type A for the treatment of chronic neck pain after neck dissection.
Vasan CW; Liu WC; Klussmann JP; Guntinas-Lichius O
Head Neck; 2004 Jan; 26(1):39-45. PubMed ID: 14724905
[TBL] [Abstract][Full Text] [Related]
3. The analgesic effect of botulinum-toxin A on postwhiplash neck pain.
Braker C; Yariv S; Adler R; Badarny S; Eisenberg E
Clin J Pain; 2008 Jan; 24(1):5-10. PubMed ID: 18180629
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type A injection in alleviating postoperative pain and improving quality of life in lower extremity limb lengthening and deformity correction: a pilot study.
Hamdy RC; Montpetit K; Raney EM; Aiona MD; Fillman RR; MacKenzie W; McCarthy J; Chafetz RS; Thomas SS; Tamayo CM; Littleton AG; Ruck-Gibis J; Takahashi SN; Rinaldi M; Finley GA; Platt RW; Dahan-Oliel N
J Pediatr Orthop; 2009; 29(5):427-34. PubMed ID: 19568011
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin in the treatment of first bite syndrome.
Ali MJ; Orloff LA; Lustig LR; Eisele DW
Otolaryngol Head Neck Surg; 2008 Nov; 139(5):742-3. PubMed ID: 18984279
[No Abstract] [Full Text] [Related]
6. Treatment of whiplash associated neck pain [corrected] with botulinum toxin-A: a pilot study.
Freund BJ; Schwartz M
J Rheumatol; 2000 Feb; 27(2):481-4. PubMed ID: 10685817
[TBL] [Abstract][Full Text] [Related]
7. Prospective randomized evaluation of periureteral botulinum toxin type A injection for ureteral stent pain reduction.
Gupta M; Patel T; Xavier K; Maruffo F; Lehman D; Walsh R; Landman J
J Urol; 2010 Feb; 183(2):598-602. PubMed ID: 20018320
[TBL] [Abstract][Full Text] [Related]
8. Treatment of chronic low back pain with successive injections of botulinum toxin a over 6 months: a prospective trial of 60 patients.
Ney JP; Difazio M; Sichani A; Monacci W; Foster L; Jabbari B
Clin J Pain; 2006 May; 22(4):363-9. PubMed ID: 16691090
[TBL] [Abstract][Full Text] [Related]
9. Use of botulinum toxin type A for chronic cough: a neuropathic model.
Chu MW; Lieser JD; Sinacori JT
Arch Otolaryngol Head Neck Surg; 2010 May; 136(5):447-52. PubMed ID: 20479373
[TBL] [Abstract][Full Text] [Related]
10. Botulinum neurotoxin-A for treatment of refractory neck pain: a randomized, double-blind study.
Miller D; Richardson D; Eisa M; Bajwa RJ; Jabbari B
Pain Med; 2009 Sep; 10(6):1012-7. PubMed ID: 19594841
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic use of botulinum toxin type A in treating neck and upper-back pain of myofascial origin: a pilot study.
Lew HL; Lee EH; Castaneda A; Klima R; Date E
Arch Phys Med Rehabil; 2008 Jan; 89(1):75-80. PubMed ID: 18164334
[TBL] [Abstract][Full Text] [Related]
12. A prospective randomized controlled study of the role of botulinum toxin in whiplash-associated disorder.
Carroll A; Barnes M; Comiskey C
Clin Rehabil; 2008 Jun; 22(6):513-9. PubMed ID: 18511531
[TBL] [Abstract][Full Text] [Related]
13. [Safety and tolerance of single-dose botulinum toxin Type A treatment in 204 patients with spasticity and localized associated symptoms. Austrian and German botulinum toxin A spasticity study group].
Wissel J; Müller J; Heinen F; Mall V; Sojer M; Ebersbach G; Poewe W
Wien Klin Wochenschr; 1999 Oct; 111(20):837-42. PubMed ID: 10586488
[TBL] [Abstract][Full Text] [Related]
14. Impact of neck dissection on quality of life.
Kuntz AL; Weymuller EA
Laryngoscope; 1999 Aug; 109(8):1334-8. PubMed ID: 10443845
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin type-A (BOTOX) in the treatment of occipital neuralgia: a pilot study.
Taylor M; Silva S; Cottrell C
Headache; 2008; 48(10):1476-81. PubMed ID: 19076646
[TBL] [Abstract][Full Text] [Related]
16. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
Elovic EP; Brashear A; Kaelin D; Liu J; Millis SR; Barron R; Turkel C
Arch Phys Med Rehabil; 2008 May; 89(5):799-806. PubMed ID: 18452724
[TBL] [Abstract][Full Text] [Related]
17. Evaluating effects of preservative-containing saline solution on pain perception during botulinum toxin type-a injections at different locations: a prospective, single-blinded, randomized controlled trial.
Sarifakioglu N; Sarifakioglu E
Aesthetic Plast Surg; 2005; 29(2):113-5. PubMed ID: 15815811
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.
Harden RN; Cottrill J; Gagnon CM; Smitherman TA; Weinland SR; Tann B; Joseph P; Lee TS; Houle TT
Headache; 2009 May; 49(5):732-43. PubMed ID: 19178577
[TBL] [Abstract][Full Text] [Related]
19. Low back ache treatment with botulinum neurotoxin type A. Local experience in Kuwait.
Nagarajan V; Al-Shubaili A; Ayad YM; Alexander J; Al-Ramezi K
Med Princ Pract; 2007; 16(3):181-6. PubMed ID: 17409751
[TBL] [Abstract][Full Text] [Related]
20. Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year followup.
Giannantoni A; Porena M; Costantini E; Zucchi A; Mearini L; Mearini E
J Urol; 2008 Mar; 179(3):1031-4. PubMed ID: 18206941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
